Patients with T2D who received GLP-1RAs or SGLT2 inhibitors were not associated with an increased risk for ARDs compared with DPP4 inhibitors.

The debut of F1's new regulations at the season opener in Australia raised questions, and ESPN answers the five biggest ahead ...

The legal tampering period is underway, and Day 1 of NFL free agency saw some huge contracts being thrown around. Not so much ...

Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors demonstrated a nearly 50% lower risk for systemic autoimmune rheumatic disease vs. those who received dipeptidyl ...

Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...

Daily intake of avocado and mango may improve endothelial function in people with prediabetes, according to new data ...

Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sonida Senior Living Q4 and Full Year 2025 ...

Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of ...

As overall AdEx rises, traditional media contracts. Ajit Varghese decodes PMAR 2026 and explains the structural reset ...

Nextpower ™ (NASDAQ: NXT), a leading provider of intelligent power generation technology and solutions for solar power plants, today announced the validation of its near-term carbon emissions ...

Stop falling for misleading headlines. Understand the difference between correlation and causation, and learn how researchers prove real scientific facts.

Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics ...